


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.65%
+1.73%
+105.63%
+0.21%
ACXP
Acurx Pharmaceuticals
$4.65
Chart
$6.8 (-31.62%)
$4.55 (+2.20%)
$0.57 (+715.79%)
$1.15 (+304.35%)
ACXP has Medium risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

ACXP overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
![]()
ACXP Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ACXP Street Sentiment is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is ACXP current stock price?
What are ACXP stock strengths?
What risks are associated with ACXP stock?
When is ACXP next earnings report?
What is ACXP market cap and volume?
What is ACXP's current Stock IQ?
Should I buy ACXP stock right now?
Is ACXP a Strong Buy right now?
What does a 'Strong Buy' rating mean for ACXP?
What does a 'Strong Sell' rating mean for ACXP?
What factors influence ACXP's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.65%
+1.73%
+105.63%
+0.21%
ACXP
Acurx Pharmaceuticals
Current Price
$4.65

Chart
$6.8 (-31.62%)
$4.55 (+2.20%)
$0.57 (+715.79%)
$1.15 (+304.35%)
ACXP Analysts Opinion
ACXP Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
![]()
ACXP Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ACXP Street Sentiment is extremely bullish and have negative views on the near-term outlook
ACXP has Medium risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

Average key support and resistance price levels.
ACXP Latest Analysis
Acurx Pharmaceuticals Inc. (NASDAQ:ACXP) Q3 2025 Earnings Call Transcript. Acurx Pharmaceuticals Inc. (NASDAQ:ACXP) Q3 2025 Earnings Call Transcript November 12 2025 Acurx Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-1.23 expectations were $-1.61. Operator: Welcome to the Acurx Pharmaceuticals’. third quarter 2025 conference call and business update. At this time all participants are in a listen-only mode. A brief question-and-answer session will follow [….]
Thu Nov 13, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ACXP Stock trends
ACXP Stock performance
ACXP Stock analysis
ACXP investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.